ScholarWorksIndianapolis
  • Communities & Collections
  • Browse ScholarWorks
  • English
  • Català
  • Čeština
  • Deutsch
  • Español
  • Français
  • Gàidhlig
  • Italiano
  • Latviešu
  • Magyar
  • Nederlands
  • Polski
  • Português
  • Português do Brasil
  • Suomi
  • Svenska
  • Türkçe
  • Tiếng Việt
  • Қазақ
  • বাংলা
  • हिंदी
  • Ελληνικά
  • Yкраї́нська
  • Log In
    or
    New user? Click here to register.Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Huang, Zhijun"

Now showing 1 - 2 of 2
Results Per Page
Sort Options
  • Loading...
    Thumbnail Image
    Item
    Effectiveness and safety of camrelizumab-containing neoadjuvant therapy in patients with esophageal squamous cell carcinoma: a prospective multicenter observational cohort study
    (AME, 2023) Zhang, Yi; Shen, Guoyi; Xu, Rongyu; Huang, Guozhong; Huang, Zhijun; Duan, Hongbing; Yang, Shengsheng; Zheng, Qingfeng; Yang, Libao; Liu, Rongxing; Ma, Liangyun; Chen, Shaogeng; Yi, Yunfeng; Zhang, Zheming; Li, Kezhi; Birdas, Thomas J.; Koyanagi, Kazuo; Simone, Charles B., II; Surgery, School of Medicine
    Background: Camrelizumab has been demonstrated to be a feasible treatment option for locally advanced esophageal squamous cell carcinoma (ESCC) when combined with neoadjuvant chemotherapy. This trial was conducted to investigate the effectiveness and safety of camrelizumab-containing neoadjuvant therapy in patients with ESCC in daily practice. Methods: This prospective multicenter observational cohort study was conducted at 13 tertiary hospitals in Southeast China. Patients with histologically or cytologically confirmed ESCC [clinical tumor-node-metastasis (cTNM) stage I-IVA] who had received at least one dose of camrelizumab-containing neoadjuvant therapy were eligible for inclusion. Results: Between June 1, 2020 and July 13, 2022, 255 patients were enrolled and included. The median age was 64 (range, 27 to 82) years. Most participants were male (82.0%) and had clinical stage III-IVA diseases (82.4%). A total of 169 (66.3%) participants underwent surgical resection; 146 (86.4%) achieved R0 resection, and 36 (21.3%) achieved pathological complete response (pCR). Grades 3-5 adverse events (AEs) were experienced by 14.5% of participants. Reactive cutaneous capillary endothelial proliferation occurred in 100 (39.2%) of participants and all were grade 1 or 2. Conclusions: Camrelizumab-containing neoadjuvant therapy has acceptable effectiveness and safety profiles in real-life ESCC patients.
  • Loading...
    Thumbnail Image
    Item
    Responses of Chinese fir and Schima superba seedlings to light gradients: Implications for the restoration of mixed broadleaf-conifer forests from Chinese fir monocultures
    (Elsevier, 2018-07) Liu, Bo; Liu, Qingqing; Daryanto, Stefani; Guo, Si; Huang, Zhijun; Wang, Zhengning; Wang, Lixin; Ma, Xiangqing; Earth Sciences, School of Science
    Although Chinese fir (Cunninghamia lanceolata (Lamb.) Hook) plantations are widely grown for timber production in southern China, they have low biodiversity and provide limited ecosystem services. To address this problem, C. lanceolata are increasingly mixed with broadleaf Schima superba Gardn. & Champ. (Theaceae). The success of these mixed plantations relies on introducing each species in the appropriate sequence, which requires understanding how tree species respond to light variations. We therefore compared S. superba and C. lanceolata seedling light tolerance in shaded houses under five light gradients (5%, 15%, 40%, 60%, and 100% sunlight). Our findings showed that S. superba seedlings exhibited greater net height increment (ΔHt), net diameter growth (ΔDia), leaf area, root mass, stem mass, leaf mass, and total mass under low light conditions (15% sunlight). However, as sunlight increased, these growth variables became higher in C. lanceolata seedlings. With more sunlight, both species experienced a drop in height to diameter ratio (HDR), and specific leaf area (SLA), but an elevated root to shoot ratio. Additionally, under the same light levels, S. superba seedlings exhibited greater leaf area and root to shoot ratio than C. lanceolata seedlings. Our results suggested that S. superba might be more suitable for underplanting beneath a heavy canopy due to its shade-tolerant traits. In contrast, C. lanceolata was less shade-tolerant, having an optimum seedling growth under full sunlight. These findings suggest that underplanting S. superba seedlings in C. lanceolata monoculture plantation (i.e., underplanting regeneration approach) could be a better silvicultural alternative than simultaneously planting both seedlings.
About IU Indianapolis ScholarWorks
  • Accessibility
  • Privacy Notice
  • Copyright © 2025 The Trustees of Indiana University